Sutro Biopharma, Inc.

STRONasdaqCIK 1382101HealthcareFiscal year ends Dec 31

Share this page

Link

Story card, 1080 × 1920

Reports and events: 136 filings

Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.

What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.

Sutro Biopharma, Inc., Reports and events
Filed	Form	What it is	Accession number
2020-09-0917:23 ET	8-K	8.01 Other events; 9.01 Financial statements and exhibits	0001564590-20-043014
2020-09-0419:00 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation	0001564590-20-042563
2020-08-0607:03 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-20-037231
2020-08-0618:00 ET	10-Q	Quarterly reportPeriod 2020-06-30	0001564590-20-036997
2020-06-1507:21 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001564590-20-029235
2020-06-0516:43 ET	8-K	5.07 Shareholder vote results	0001564590-20-028506
2020-05-1217:14 ET	8-K	1.01 Entry into a material agreement; 9.01 Financial statements and exhibits	0001564590-20-024736
2020-05-1116:27 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-20-024242
2020-05-1118:02 ET	10-Q	Quarterly reportPeriod 2020-03-31	0001564590-20-023689
2020-05-0417:12 ET	10-K/A	Annual report, amendedPeriod 2019-12-31	0001564590-20-020872
2020-04-2708:00 ET	8-K	2.02 Results of operations; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits	0001564590-20-018684
2020-04-2416:27 ET	DEF 14A	Proxy statementPeriod 2020-06-05	0001564590-20-018532
2020-03-1606:04 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-20-010955
2020-03-1618:11 ET	10-K	Annual reportPeriod 2019-12-31	0001564590-20-010890
2020-03-0319:41 ET	8-K	1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity	0001564590-20-008232
2020-01-0817:00 ET	8-K	5.02 Departure or appointment of officers or directors	0001564590-20-000514
2019-11-0808:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-19-042019
2019-11-0817:59 ET	10-Q	Quarterly reportPeriod 2019-09-30	0001564590-19-041909
2019-10-3019:30 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001564590-19-038415
2019-08-1406:29 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-19-031936
2019-08-1418:42 ET	10-Q	Quarterly reportPeriod 2019-06-30	0001564590-19-031883
2019-06-2416:18 ET	8-K	5.02 Departure or appointment of officers or directors	0001564590-19-023255
2019-06-1706:05 ET	8-K	7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits	0001564590-19-022611
2019-06-1016:57 ET	8-K	5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results	0001564590-19-022125
2019-05-1507:00 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-19-019255
2019-05-1520:41 ET	10-Q	Quarterly reportPeriod 2019-03-31	0001564590-19-019236
2019-05-0718:11 ET	8-K	8.01 Other events	0001564590-19-016067
2019-04-2619:34 ET	DEF 14A	Proxy statementPeriod 2019-06-07	0001564590-19-013160
2019-04-0110:22 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001564590-19-010338
2019-04-0119:38 ET	10-K	Annual reportPeriod 2018-12-31	0001564590-19-010253
2018-11-1520:12 ET	8-K	2.02 Results of operations; 9.01 Financial statements and exhibits	0001193125-18-326967
2018-11-1416:02 ET	10-Q	Quarterly reportPeriod 2018-09-30	0001564590-18-029555
2018-11-0817:09 ET	8-K	5.02 Departure or appointment of officers or directors	0001193125-18-322690
2018-10-0916:18 ET	SC 13D	Ownership report, active investor	0001193125-18-295955
2018-09-1707:03 ET	S-1/A	Registration statement, amended	0001193125-18-274668
2018-08-2916:36 ET	S-1	Registration statement	0001193125-18-262012

Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:12 ET. Listed shows no prices and gives no investment advice.